SYNERGEN’s SENSATIONAL SURGE SIGNIFIES "STREET" APPEAL OF LONG-TERM PROSPECTS; BIOTECH BOOM BRINGS WIDE GROUP BACK; 17 ISSUES GAIN MORE THAN 50%